Dysmenorrhea Treatment Market - Forecast(2019 - 2024)

Report Code: HCR 0284 Report Format: PDF + Excel Database
Dysmenorrhea refers to painful menstruation. There are two types of Dysmenorrhea - primary and secondary. In Primary Dysmenorrhea recurrent and painful menstrual cramps occur one or two days before menstrual bleeding, and is felt in the lower abdomen, back, or thigh and is mild to severe in nature, typically lasting 12 to 72 hours. Nausea, vomiting, fatigue, and even diarrhea may also be seen in this type of condition. Primary Dysmenorrhea affects 45 and 95% of menstruating women.

Secondary Dysmenorrhea is characterized by pain, due to a disorder or infection in the woman's reproductive organs; the pain usually begins earlier in the menstrual cycle and lasts upto common menstrual cramps.

Various classes of drugs are used to treat Dysmenorrhea either as monotherpy or as combination therapy. Drug regimen is chosen based on Dysmenorrhea type. Non-steroidal anti-inflammatory drugs (NSAIDs), Glyceryl trinitrate, Progestin regimens and Levonorgestrel intrauterine system (LN-IUS). Surgical options like Laparoscopy, Hysterectomy, Presacral neurectomy, and Laparoscopic uterosacral nerve ablation are also available to treat the condition.

Globally, Dysmenorrhea affects 60-93% of women, of which more than 50% are post pubescent menstruating women. Major factors driving market of Dysmenorrhea are high consciousness level, government campaigns and growing concern about Dysmenorrhea among females. However, long term treatment, morbidity, and traditional family values would restrain the growth of market.

This report provides information on Dysmenorrhea treatment market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to Dysmenorrhea treatment market.
 
Dysmenorrhea Treatment Market

Geographically, USA, Europe and Asia pacific are considered as the major markets for Dysmenorrhea. North America owing has high incidence of Dysmenorrhea. Europe is the second largest market with existence of a large number of Dysmenorrhea patients. North America and Europe have high healthcare spending, well established infrastructure, high awareness about the disease and high availability of its treatments.

Asia-Pacific is expected to have rapid growth in Dysmenorrhea treatment market because of changing infrastructure, educational program, increase in purchasing power, and increased awareness for clinical facilities in the regions. China, Japan, India are the emerging markets they have high market potential for Dysmenorrhea. In these countries growing awareness campaigns is enhancing the Dysmenorrhea treatment market.

This report identifies global Dysmenorrhea treatment market on the basis of type and regional market as follows:
  • Dysmenorrhea treatment market is segmented based on type primary and secondary
  • A detailed analysis by region – North America, Europe, Asia Pacific (APAC) and Rest of the World (RoW), has been provided in this report
Sample Companies Profiled in this Report are:
  • Novartis AG
  • Merck, Inc.
  • Bayer Schering Pharma AG,
  • Abbott Healthcare
  • Pfizer, Inc.
  • 10+
1. Dysmenorrhea – Market Overview
2. Executive Summary
3. Dysmenorrhea - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Dysmenorrhea Market- Market Forces
   4.1. Drivers
      4.1.1. Increasing awareness amongst people
      4.1.2. Increasing number of treatment options
   4.2. Restraints
      4.2.1. Traditional family values
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Force Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Customers 
      4.5.3. Threat of New Entrants 
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Dysmenorrhea Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Dysmenorrhea Market, By Type
   6.1. Primary Dysmenorrhea
   6.2. Secondary Dysmenorrhea
7. Dysmenorrhea Market, By Geography
   7.1. Introduction
   7.2. North America
      7.2.1. US
      7.2.2. Canada
      7.2.3. Mexico
   7.3. Europe
      7.3.1. U.K.
      7.3.2. France
      7.3.3. Germany
      7.3.4. Italy
      7.3.5. Spain
      7.3.6. Rest of Europe
   7.4. Asia Pacific
      7.4.1. China
      7.4.2. South Korea
      7.4.3. Japan
      7.4.4. India
      7.4.5. Rest of Asia Pacific
   7.5. RoW
8. Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Merck Inc.
   9.2. Novartis AG
   9.3. Bayer Pharma
   9.4. Abbott Healthcare
   9.5. Pfizer
   9.6. Roche pharma
   9.7. TAJ Pharma
   9.8. Mylan Pharmaceuticals
   9.9. Nobel Pharmaceuticals
   9.10. Juniper Pharmaceuticals
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
List of Tables:

Table 1: Dysmenorrhea Treatment Market Overview 2019-2024
Table 2: Dysmenorrhea Treatment Market Leader Analysis 2018-2019 (US$)
Table 3: Dysmenorrhea Treatment Market Product Analysis 2018-2019 (US$)
Table 4: Dysmenorrhea Treatment Market End User Analysis 2018-2019 (US$)
Table 5: Dysmenorrhea Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Dysmenorrhea Treatment Market Financial Analysis 2018-2019 (US$)
Table 7: Dysmenorrhea Treatment Market Driver Analysis 2018-2019 (US$)
Table 8: Dysmenorrhea Treatment Market Challenges Analysis 2018-2019 (US$)
Table 9: Dysmenorrhea Treatment Market Constraint Analysis 2018-2019 (US$)
Table 10: Dysmenorrhea Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Dysmenorrhea Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Dysmenorrhea Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Dysmenorrhea Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Dysmenorrhea Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Dysmenorrhea Treatment Market Value Chain Analysis 2018-2019 (US$)
Table 16: Dysmenorrhea Treatment Market Pricing Analysis 2019-2024 (US$)
Table 17: Dysmenorrhea Treatment Market Opportunities Analysis 2019-2024 (US$)
Table 18: Dysmenorrhea Treatment Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Dysmenorrhea Treatment Market Supplier Analysis 2018-2019 (US$)
Table 20: Dysmenorrhea Treatment Market Distributor Analysis 2018-2019 (US$)
Table 21: Dysmenorrhea Treatment Market Trend Analysis 2018-2019 (US$)
Table 22: Dysmenorrhea Treatment Market Size 2018 (US$)
Table 23: Dysmenorrhea Treatment Market Forecast Analysis 2019-2024 (US$)
Table 24: Dysmenorrhea Treatment Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Dysmenorrhea Treatment Market By Type, Revenue & Volume, By Primary Dysmenorrhea, 2019-2024 ($)
Table 27: Dysmenorrhea Treatment Market By Type, Revenue & Volume, By Secondary Dysmenorrhea, 2019-2024 ($)
Table 28: North America Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 29: South america Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 30: Europe Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 31: APAC Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 32: Middle East & Africa Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 33: Russia Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 34: Israel Dysmenorrhea Treatment Market , Revenue & Volume, By Type, 2019-2024 ($)
Table 35: Top Companies 2018 (US$)Dysmenorrhea Treatment Market , Revenue & Volume
Table 36: Product Launch 2018-2019Dysmenorrhea Treatment Market , Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019Dysmenorrhea Treatment Market , Revenue & Volume


List of Figures:

Figure 1: Overview of Dysmenorrhea Treatment Market 2019-2024
Figure 2: Market Share Analysis for Dysmenorrhea Treatment Market 2018 (US$)
Figure 3: Product Comparison in Dysmenorrhea Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Dysmenorrhea Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Dysmenorrhea Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Dysmenorrhea Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Dysmenorrhea Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Dysmenorrhea Treatment Market 2018
Figure 9: Average Selling Price in Dysmenorrhea Treatment Market 2019-2024
Figure 10: Top Opportunites in Dysmenorrhea Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Dysmenorrhea Treatment Market
Figure 12: GlobalBy TypeDysmenorrhea Treatment Market Revenue, 2019-2024 ($)
Figure 13: Global Dysmenorrhea Treatment Market - By Geography
Figure 14: Global Dysmenorrhea Treatment Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Dysmenorrhea Treatment Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 17: US Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 92: China Dysmenorrhea Treatment Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Dysmenorrhea Treatment Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Dysmenorrhea Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Dysmenorrhea Treatment Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Dysmenorrhea Treatment Market
Figure 130: Developments, 2018-2019*Dysmenorrhea Treatment Market
Figure 131: Company 1 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Dysmenorrhea Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Dysmenorrhea Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Dysmenorrhea Treatment Market Net Sales Share, By Geography, 2018 (%)